ASYMCHEM LAB.(TIAN.)H YC1 - Asset Resilience Ratio

Latest as of March 2026: 5.07%

ASYMCHEM LAB.(TIAN.)H YC1 (7K90) has an Asset Resilience Ratio of 5.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€1.05 Billion

≈ $1.23 Billion USD Cash + Short-term Investments

Total Assets

€20.70 Billion

≈ $24.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how ASYMCHEM LAB.(TIAN.)H YC1's Asset Resilience Ratio has changed over time. See 7K90 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down ASYMCHEM LAB.(TIAN.)H YC1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ASYMCHEM LAB.(TIAN.)H YC1 stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.05 Billion	5.07%
Total Liquid Assets	€1.05 Billion	5.07%

Asset Resilience Insights

Limited Liquidity: ASYMCHEM LAB.(TIAN.)H YC1 maintains only 5.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ASYMCHEM LAB.(TIAN.)H YC1 Industry Peers by Asset Resilience Ratio

Compare ASYMCHEM LAB.(TIAN.)H YC1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for ASYMCHEM LAB.(TIAN.)H YC1 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for ASYMCHEM LAB.(TIAN.)H YC1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.51%	€1.12 Billion ≈ $1.31 Billion	€20.28 Billion ≈ $23.71 Billion	-2.48pp
2024-12-31	7.98%	€1.54 Billion ≈ $1.80 Billion	€19.29 Billion ≈ $22.55 Billion	-1.66pp
2023-12-31	9.64%	€1.91 Billion ≈ $2.23 Billion	€19.77 Billion ≈ $23.11 Billion	-2.15pp
2022-12-31	11.79%	€2.15 Billion ≈ $2.51 Billion	€18.24 Billion ≈ $21.32 Billion	+9.15pp
2021-12-31	2.65%	€401.20 Million ≈ $469.04 Million	€15.16 Billion ≈ $17.72 Billion	--

pp = percentage points

About ASYMCHEM LAB.(TIAN.)H YC1

F:7K90 Germany Biotechnology

Market Cap

$426.29 Million

€364.63 Million EUR

Market Cap Rank

#12817 Global

#1371 in Germany

Share Price

€13.10

Change (1 day)

+0.77%

52-Week Range

€7.45 - €14.50

All Time High

€14.50